Who owns BELITE BIO INC?
- Ticker: BLTE
- CUSIP Number: 07782b104
Tip: Access positions for across all investors
Analyze quarterly positions in Belite Bio with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Belite Bio stock
Who bought or sold BELITE BIO INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Darwin Global Management | 3.1M | $456M | 1% | Mar 2026 |
|
| Paradigm Biocapital Advisors | 1.1M | $178M | 100% | Mar 2026 |
|
| UBS Group | 768k | $123M | 497% | Mar 2026 |
|
| Rtw Investments | 715k | $114M | 129% | Dec 2025 |
|
| Millennium Management | 570k | $91M | 2% | Mar 2026 |
|
| Holocene Advisors | 495k | $79M | 488% | Mar 2026 |
|
| Eventide Asset Management | 383k | $61M | 96% | Dec 2025 |
|
| Deerfield Management Company | 304k | $49M | 30% | Mar 2026 |
|
| Morgan Stanley | 201k | $32M | 619% | Mar 2026 |
|
| Marshall Wace | 193k | $31M | 3% | Dec 2025 |
|
| Perceptive Advisors | 152k | $24M | -63% | Mar 2026 |
|
| Patient Square Capital | 117k | $19M | 100% | Mar 2026 |
|
| Duquesne Family Office | 106k | $17M | 100% | Mar 2026 |
|
| Goldman Sachs Group | 106k | $17M | 137% | Mar 2026 |
|
| MPM Oncology Impact Management | 88k | $14M | 0% | Mar 2026 |
|
| Fred Alger Management | 63k | $10M | -21% | Mar 2026 |
|
| Longaeva Partners | 34k | $5.3M | 100% | Mar 2026 |
|
| TD Asset Management | 33k | $5.3M | 100% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 33k | $5.2M | 1229% | Mar 2026 |
|
| ADAR1 Capital Management | 27k | $4.3M | -33% | Mar 2026 |
|
| Artia Global Partners | 25k | $4.0M | 39% | Mar 2026 |
|
| Quadrature Capital | 25k | $4.0M | 100% | Dec 2025 |
|
| Superstring Capital Management | 25k | $4.0M | 100% | Dec 2025 |
|
| Aquatic Capital Management | 20k | $3.2M | 100% | Mar 2026 |
|
| Affinity Asset Advisors | 20k | $3.2M | 100% | Dec 2025 |
|
| Partner Fund Management | 20k | $3.2M | 100% | Dec 2025 |
|
| Manufacturers Life Insurance Company | 20k | $3.1M | 100% | Mar 2026 |
|
| Squarepoint Ops | 17k | $2.7M | 100% | Mar 2026 |
|
| Bank Of Montreal | 16k | $2.5M | 100% | Mar 2026 |
|
| State Street Corporation | 16k | $2.5M | 19% | Dec 2025 |
|
| Trexquant Investment | 15k | $2.4M | 100% | Mar 2026 |
|
| Balance Capital Partners | 15k | $2.3M | 100% | Mar 2026 |
|
| Exome Asset Management | 14k | $2.3M | 100% | Dec 2025 |
|
| Jane Street | 12k | $1.9M | -62% | Mar 2026 |
|
| Hrt Financial | 11k | $1.7M | 34% | Mar 2026 |
|
| Blackstone Group | 11k | $1.7M | 100% | Mar 2026 |
|
| Geode Capital Management | 10k | $1.7M | 0% | Mar 2026 |
|
| Voleon Capital Management | 7.9k | $1.3M | 100% | Mar 2026 |
|
| Wellington Management Company | 6.2k | $991k | 100% | Dec 2025 |
|
| Arrowpoint Investment Partners | 6.0k | $957k | 97% | Mar 2026 |
|
| Amundi | 4.2k | $671k | 100% | Mar 2026 |
|
| SmartHarvest Portfolios | 4.2k | $668k | 100% | Mar 2026 |
|
| Barclays | 4.2k | $668k | 100% | Dec 2025 |
|
| Bank of America Corporation | 3.8k | $602k | 100% | Mar 2026 |
|
| High Net Worth Advisory Group | 3.5k | $558k | 0% | Mar 2026 |
|
| Springbok Capital Management | 3.1k | $499k | 100% | Dec 2025 |
|
| Convergence Financial | 3.0k | $473k | 100% | Mar 2026 |
|
| Ameriprise Financial | 2.8k | $441k | -79% | Mar 2026 |
|
| Yeomans Consulting Group | 2.4k | $384k | 100% | Dec 2025 |
|
| Axq Capital | 2.4k | $378k | 100% | Mar 2026 |
|
| Royal Bank of Canada | 2.3k | $360k | 100% | Mar 2026 |
|
| SG Americas Securities | 2.1k | $342k | -22% | Mar 2026 |
|
| Citadel Advisors | 2.0k | $320k | -60% | Mar 2026 |
|
| Dymon Asia Capital | 1.9k | $303k | 100% | Mar 2026 |
|
| Virtus Investment Advisers | 1.9k | $301k | 3% | Dec 2025 |
|
| GAMMA Investing | 1.7k | $272k | -4% | Mar 2026 |
|
| GSA Capital Partners | 1.6k | $262k | 12% | Mar 2026 |
|
| EverSource Wealth Advisors | 1.6k | $256k | 1% | Mar 2026 |
|
| Tudor Investment Corporation | 1.6k | $255k | 100% | Mar 2026 |
|
| Merit Financial Group | 1.4k | $226k | 100% | Mar 2026 |
|
| Independent Advisor Alliance | 1.3k | $210k | 0% | Mar 2026 |
|
| Mirae Asset Global Investments | 657.00 | $105k | 2% | Mar 2026 |
|
| Caitong International Asset Management | 349.00 | $56k | -36% | Mar 2026 |
|
| Advisor Group Holdings | 195.00 | $31k | 6400% | Dec 2025 |
|
| Wells Fargo & Company | 124.00 | $20k | 24% | Mar 2026 |
|
| E Fund Management | 83.00 | $13k | 100% | Mar 2026 |
|
| TD Waterhouse Canada | 70.00 | $12k | 0% | Mar 2026 |
|
| Rossby Financial, LCC | 55.00 | $9.2k | 323% | Mar 2026 |
|
| SBI Securities | 22.00 | $3.5k | -56% | Mar 2026 |
|
| Farther Finance Advisors | 15.00 | $2.5k | -85% | Mar 2026 |
|
| NISA Investment Advisors | 13.00 | $2.1k | 100% | Mar 2026 |
|
| Jones Financial Companies, L.L | 6.00 | $960.000000 | 100% | Dec 2025 |
|
| Bell Investment Advisors | 4.00 | $638.000000 | 100% | Mar 2026 |
|
| Citigroup | 1.00 | $159.000000 | 100% | Mar 2026 |
|
Who sold out of Belite Bio?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| RA Capital Management | Dec 2025 | 433k | $69M |
| Point72 Asset Management | Dec 2025 | 284k | $46M |
| Western Standard | Dec 2025 | 60k | $9.6M |
| Soleus Capital Management | Dec 2025 | 40k | $6.5M |
| Woodline Partners | Dec 2025 | 18k | $2.9M |
| Boothbay Fund Management | Dec 2025 | 12k | $1.9M |
| Jpmorgan Chase & Co | Sep 2025 | 9.8k | $726k |
| Stempoint Capital | Dec 2025 | 9.2k | $1.5M |
| Seven Fleet Capital Management | Dec 2025 | 9.2k | $1.5M |
| PSP Research | Dec 2025 | 3.4k | $551k |
| Y-Intercept | Dec 2025 | 3.2k | $504k |
| Renaissance Technologies | Sep 2025 | 2.8k | $208k |
| Skopos Labs | Dec 2025 | 1.7k | $287k |
| Persistent Asset Partners | Dec 2025 | 673.00 | $108k |
| China Universal Asset Management | Dec 2025 | 500.00 | $80k |